{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:02:50Z","timestamp":1791756170511,"version":"4.3.4"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To characterize the clinical manifestations of yellow fever disease and identify risk factors for mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective study was conducted in the referral center for infectious diseases (Hospital Eduardo de Menezes-HEM) in Belo Horizonte, Minas Gerais, Brazil. Analysis included data from 283 patients with confirmed YF infection older than 13 years old who presented to HEM between January 2017 and June 2018. In-hospital mortality (hypothesis formulated after data collection), demographic factors and clinical and laboratory assessments were used.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Study patients were mainly men (87.6%), with a median age of 46.0 (IQR 36.5, 57.0). 131 (46.3%) patients were admitted to the ICU, and 62 (22.0%) used invasive mechanical ventilation for a median of 2 days (IQR 1, 3). The median (IQR) total length of stay (LOS) in the ICU was 6 days (IQR 4, 8). The in-hospital mortality rate was 24.0%. Age was significantly higher in fatal (median 49.5, IQR 41.0, 61.0]) than in non-fatal cases [46 (36, 55)] (<jats:italic>p<\/jats:italic> &amp;lt; 0.01). Male sex was associated with an increased risk of death (RR 4.66, 95% CI 1.19, 18.2; <jats:italic>p<\/jats:italic> &amp;lt; 0.01). Most common symptoms and signs on admission to HEM were fever (31.9%), myalgia (27.8%), jaundice (24.3%), headache (23.9%), abdominal pain (16.1%), vomiting (12.2%), weakness (10.4%), and arthralgias (10.0%). Initial viral load above the cutoff of 4.45 log<jats:sub>10<\/jats:sub> copies\/mL was significantly associated with death prior to discharge (OR 12.2; CI 2.83, 92.3). Five factors were significantly related to increased odds of death prior to discharge: log-transformed AST (OR 3.65; CI 2.02, 7.81; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), log-transformed INR (OR 7.40; CI 1.31, 33.0; <jats:italic>p<\/jats:italic> = 0.010), log-transformed lactate (OR 4.57; CI 1.48, 17.1; <jats:italic>p<\/jats:italic> = 0.013), log-transformed WBC (OR 4.33; CI 1.19, 18.5; <jats:italic>p<\/jats:italic> = 0.034), and age (OR 1.06; CI 1.01, 1.12; <jats:italic>p<\/jats:italic> = 0.026).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and relevance<\/jats:title><jats:p>AST, INR, lactate, WBC, and age are statistically associated with death prior to discharge in YF patients. These clinical markers should be applied to improve patient screening and management during future YF epidemics.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1505005","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T08:54:44Z","timestamp":1738140884000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil"],"prefix":"10.3389","volume":"12","author":[{"given":"Max","family":"McClure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela Maur\u00edcio de","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Soares","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita Teixeira","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Rodrigues Barbosa","family":"Fradico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle Cardoso","family":"Mar\u00e7al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Soares Coelho","family":"Fonte Boa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Maur\u00edcio Castro","family":"Bragato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Augusto de Almeida","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Fabiano do Carmo","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Calzavara-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario Brock","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia Lopes de Brito","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Augusto","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaysa Drummond Palmeira","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia Fernandes","family":"Cota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Ant\u00f4nio","family":"Pascoal-Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00e2nia Paiva","family":"Drumond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Desiree","family":"LaBeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Yellow Fever Collaborative Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever.","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization.","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med."},{"key":"B3","year":"2016","journal-title":"Angola Grapples with Worst Yellow Fever Outbreak in 30 Years."},{"key":"B4","year":"2018","journal-title":"Yellow Fever - Republic of the Congo."},{"key":"B5","year":"2019","journal-title":"Yellow Fever - Brazil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: An update.","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1277-7","article-title":"Recent sylvatic yellow fever virus transmission in Brazil: The news from an old disease.","volume":"17","author":"Silva","year":"2020","journal-title":"Virol J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: Epidemiology and prevention.","volume":"44","author":"Barnett","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/v12020222","article-title":"Late-relapsing hepatitis after yellow fever.","volume":"12","author":"Rezende","year":"2020","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMc1913036","article-title":"Late-onset relapsing hepatitis associated with yellow fever.","volume":"382","author":"Casadio","year":"2020","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3201\/eid2506.190069","article-title":"Hepatitis rebound after infection with yellow fever virus.","volume":"25","author":"Denis","year":"2019","journal-title":"Emerg Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cid\/ciad249","article-title":"Characterization and investigation of risk factors for late-relapsing hepatitis after yellow fever.","volume":"77","author":"de Rezende","year":"2023","journal-title":"Clin Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever.","volume":"60","author":"Monath","year":"2003","journal-title":"Adv Virus Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"i3764","DOI":"10.1136\/bmj.i3764","article-title":"Yellow fever in Africa","volume":"354","author":"Maguire","year":"2016","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/ETLS20200187","article-title":"Re-emergence of yellow fever in the neotropics \u2014 quo vadis?","volume":"4","author":"Sacchetto","year":"2020","journal-title":"Emerg Top Life Sci."},{"key":"B16","year":"2020","journal-title":"Manual de Manejo Cl\u00ednico da Febre Amarela."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1128\/JCM.01799-12","article-title":"Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories.","volume":"50","author":"Domingo","year":"2012","journal-title":"J Clin Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v098.i11","article-title":"cutpointr: Improved estimation and validation of optimal cutpoints in R.","volume":"98","author":"Thiele","year":"2021","journal-title":"J Stat Softw."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006538","article-title":"Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018.","volume":"12","author":"de Rezende","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0035-9203(36)90014-7","article-title":"Clinical manifestations of yellow fever in the West African native as observed during four extensive epidemics of the disease in the Gold Coast and Nigeria.","volume":"30","author":"Beeuwkes","year":"1936","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B21","first-page":"577","article-title":"Yellow fever in Ghana, 1977-80.","volume":"62","author":"Agadzi","year":"1984","journal-title":"Bull. World Health Organ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1473-3099(19)30125-2","article-title":"Predictors of mortality in patients with yellow fever: An observational cohort study.","volume":"19","author":"Kallas","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trstmh.2006.04.001","article-title":"Clinical and epidemiological characteristics of yellow fever in Brazil: Analysis of reported cases 1998\u20132002.","volume":"101","author":"Tuboi","year":"2007","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4269\/ajtmh.18-0882","article-title":"Yellow fever: Factors associated with death in a hospital of reference in infectious diseases, S\u00e3o Paulo, Brazil, 2018.","volume":"101","author":"Ribeiro","year":"2019","journal-title":"Am J Trop Med Hyg."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511811623","author":"McNeill","year":"2010","journal-title":"Mosquito Empires."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027753","article-title":"Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: A prospective controlled cohort study.","volume":"6","author":"Roukens","year":"2011","journal-title":"PLoS One."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06535-4","article-title":"Estimating case fatality risk of severe Yellow Fever cases: Systematic literature review and meta-analysis.","volume":"21","author":"Servadio","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.1978.27.125","article-title":"An epidemic of yellow fever in central Brazil. 1972-1973. I. Epidemiological studies.","volume":"27","author":"Pinheiro","year":"1978","journal-title":"Am J Trop Med Hyg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine.","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines."},{"key":"B31","first-page":"845","article-title":"[An epidemic of yellow fever in Senegal in 1965. Epidemiological studies].","volume":"39","author":"Cornet","year":"1968","journal-title":"Bull World Health Organ."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taz04","article-title":"Severe yellow fever in Brazil: Clinical characteristics and management.","volume":"26","author":"Ho","year":"2019","journal-title":"J Travel Med."},{"key":"B33","first-page":"659","article-title":"A clinicopathological study of human yellow fever.","volume":"46","author":"Francis","year":"1972","journal-title":"Bull World Health Organ."},{"key":"B34","first-page":"143","article-title":"Estudo da coagula\u00e7\u00e3o sangu\u00ednea na febre amarela.","volume":"2","author":"de P\u00e1,dua Afonso Borges","year":"1973","journal-title":"Rev Patol Trop."},{"key":"B35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2020.01.039","article-title":"Clinical profiles and factors associated with mortality in adults with yellow fever admitted to an intensive care unit in Minas Gerais, Brazil.","volume":"93","author":"de \u00c1vila","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ajcp\/25.2.135","article-title":"Clinical pathology of yellow fever.","volume":"25","author":"Elton","year":"1955","journal-title":"Am J Clin Pathol."},{"key":"B37","first-page":"653","article-title":"Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau, Nigeria.","volume":"46","author":"Jones","year":"1972","journal-title":"Bull World Health Organ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"ofae312","DOI":"10.1093\/ofid\/ofae312","volume":"11","author":"Rezende","year":"2024","journal-title":"Sofosbuvir Off-label treatment of yellow fever patients during an outbreak in brazil, 2018: a cohort study.Open Forum Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","year":"2005","journal-title":"Control of Yellow Fever, Field Guide 2005.","DOI":"10.1016\/S0140-6736(00)79439-6"},{"key":"B40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3201\/eid2401.171310","article-title":"Yellow fever virus RNA in urine and semen of convalescent patient, Brazil.","volume":"24","author":"Barbosa","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1128\/JCM.01113-17","article-title":"Urine as sample type for molecular diagnosis of natural yellow fever virus infections.","volume":"55","author":"Reusken","year":"2017","journal-title":"J Clin Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00254-22","article-title":"Yellow fever molecular diagnosis using urine specimens during acute and convalescent phases of the disease.","volume":"60","author":"de Rezende","year":"2022","journal-title":"J Clin Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue.","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/s0264-410x(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: Recombinant live, attenuated vaccines against flavivirus infections.","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2214\/AJR.20.23455","article-title":"Ultrasound findings and laboratory predictors of early mortality in patients with severe yellow fever.","volume":"216","author":"Neves","year":"2021","journal-title":"Am J Roentgenol."},{"key":"B46","first-page":"269","year":"2013","journal-title":"Weekly Epidemiological Record: Vaccines and Vaccination Against Yellow Fever. WHO Position Paper - June 2013."},{"key":"B47","year":"2013","journal-title":"Background Paper on Yellow Fever Vaccine."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040206","article-title":"Yellow fever virus genotyping tool and investigation of suspected adverse events following yellow fever vaccination.","volume":"7","author":"Rezende","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"B49","year":"2021","journal-title":"Manual de Vigil\u00e2ncia Epidemiol\u00f3gica de Eventos Adversos p\u00f3s-Vacina\u00e7\u00e3o."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.26633\/rpsp.2018.75","article-title":"Yellow fever vaccine and risk of developing serious adverse events: A systematic review.","volume":"42","author":"Porudominsky","year":"2018","journal-title":"Rev Panam Salud Publica."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine."},{"key":"B52","first-page":"647","article-title":"Yellow fever vaccine booster doses: Recommendations of the advisory committee on immunization practices, 2015.","volume":"64","author":"Staples","year":"2015","journal-title":"Morb Mortal Wkly Rep."},{"key":"B53","year":"2016","journal-title":"Yellow Fever Strategic Response Plan June-August 2016."},{"key":"B54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/oxfordjournals.aje.a121232","article-title":"Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans.","volume":"93","author":"Monath","year":"1971","journal-title":"Am J Epidemiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(sici)1096-9071(199810)56:23.0.co;2-b","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection.","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.104","article-title":"Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.","volume":"60","author":"Lang","year":"1999","journal-title":"Am J Trop Med Hyg."},{"key":"B57","year":"2017","journal-title":"Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle."},{"key":"B58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4269\/ajtmh.1975.24.115","article-title":"The relative resistance of dengue-immune monkeys to yellow fever virus *.","volume":"24","author":"Theiler","year":"1975","journal-title":"Am J Trop Med Hyg."},{"key":"B59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4269\/ajtmh.2003.68.695","article-title":"Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.","volume":"68","author":"Xiao","year":"2003","journal-title":"Am J Trop Med Hyg."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.56257","article-title":"Anamnestic immune response to dengue and decreased severity of yellow fever.","volume":"1","author":"Izurieta","year":"2009","journal-title":"J Glob Infect Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever.","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1505005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T08:54:48Z","timestamp":1738140888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1505005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":61,"alternative-id":["10.3389\/fmed.2025.1505005"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1505005","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1505005"}}